Sirtuin modulators

Handbook of Experimental Pharmacology

Volumn 206, Issue , 2011, Pages 241-255

  Mahajan, Sumit S ^a   Leko, Vid ^a   Simon, Julian A ^a   Bedalov, Antonio ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

NAD; Sirtuin inhibitors; Sirtuins

Indexed keywords

2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; AC 93253; BETA PHENYLSPLITOMICIN; CAMBINOL; CHALCONE DERIVATIVE; DIHYDROPYRIDINE DERIVATIVE; EX 527; HYDROLASE INHIBITOR; ISONICOTINAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; RESVERATROL; SALERMIDE; SIRTINOL; SIRTUIN; SIRTUIN 1; SIRTUIN 2; SIRTUIN INHIBITOR; SPLITOMICIN; SRT 1720; STAT PROTEIN; SURAMIN; TENOVIN; TENOVIN 6; UNCLASSIFIED DRUG;

ACETYLATION; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; ARTICLE; CANCER INHIBITION; COMPETITIVE INHIBITION; CRYSTAL STRUCTURE; DRUG BINDING SITE; DRUG STRUCTURE; HIGH THROUGHPUT SCREENING; IC 50; LYMPHOMA; MELANOMA; MOLECULAR DOCKING; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; TRYPANOSOMIASIS;

ANIMALS; DRUG DESIGN; ENZYME ACTIVATION; ENZYME ACTIVATORS; HISTONE DEACETYLASE INHIBITORS; HUMANS; MOLECULAR STRUCTURE; PROTEIN CONFORMATION; SIRTUINS; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 80054767989     PISSN: 01712004     EISSN: 18650325     Source Type: Book Series    
DOI: 10.1007/978-3-642-21631-2_11     Document Type: Article

References (60)

1. Anderson RM et al (2002) Manipulation of a nuclear NAD+ salvage pathway delays aging without altering steady-state NAD+ levels. J Biol Chem 277(21):18881-18890 (Pubitemid 34952448)
2. Anderson RM et al (2003) Nicotinamide and PNC1 govern lifespan extension by calorie restriction in Saccharomyces cerevisiae. Nature 423(6936):181-185 (Pubitemid 36569542)
3. Asaba T et al (2009) Inhibition of human sirtuins by in situ generation of an acetylated lysine- ADP-ribose conjugate. J Am Chem Soc 131(20):6989-6996
4. Baur JA et al (2006) Resveratrol improves health and survival of mice on a high-calorie diet. Nature 444(7117):337-342 (Pubitemid 44764104)
5. Bedalov A et al (2001) Identification of a small molecule inhibitor of Sir2p. Proc Natl Acad Sci USA 98:15113-15118 (Pubitemid 34013978)
6. Bedalov A et al (2003) NAD-dependent deacetylase Hst1p controls biosynthesis and cellular NAD levels in Saccharomyces cerevisiae. Mol Cell Biol 23(19):7044-7054 (Pubitemid 37214670)
7. Bogan KL, Brenner C (2008) Nicotinic acid, nicotinamide, and nicotinamide riboside: a molecular evaluation of NAD+ precursor vitamins in human nutrition. Annu Rev Nutr 28:115-130
8. Bordone L, Guarente L (2005) Calorie restriction, SIRT1 and metabolism: understanding longevity. Nat Rev Mol Cell Biol 6(4):298-305 (Pubitemid 40516896)
9. Borra MT, Smith BC, Denu JM (2005) Mechanism of human SIRT1 activation by resveratrol. J Biol Chem 280(17):17187-17195 (Pubitemid 41389185)
10. Feige JN et al (2008) Specific SIRT1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation. Cell Metab 8(5):347-358
11. FulcoMet al (2003) Sir2 regulates skeletal muscle differentiation as a potential sensor of the redox state. Mol Cell 12(1):51-62
12. Grozinger CM et al (2001) Identification of a class of small molecule inhibitors of the sirtuin family of NAD-dependent deacetylases by phenotypic screening. J Biol Chem 276(42): 38837-38843
13. Guarente L (2000) Sir2 links chromatin silencing, metabolism, and aging. Genes Dev 14(9): 1021-1026 (Pubitemid 30324417)
14. Gutierrez M et al (2009) Structural and synthetic investigations of tanikolide dimer, a SIRT2 selective inhibitor, and tanikolide seco-acid from the Madagascar marine cyanobacterium Lyngbya majuscula. J Org Chem 74(15):5267-5275
15. Ha HC, Snyder SH (1999) Poly(ADP-ribose) polymerase is a mediator of necrotic cell death by ATP depletion. Proc Natl Acad Sci USA 96(24):13978-13982
16. Harikumar KB, Aggarwal BB (2008) Resveratrol: a multitargeted agent for age-associated chronic diseases. Cell Cycle 7(8):1020-1035
17. Heltweg B et al (2006) Antitumor activity of a small molecule inhibitor of human Sir2 enzymes. Cancer Res 66(8):4368-4377
18. Hirao M et al (2003) Identification of selective inhibitors of NAD+-dependent deacetylases using phenotypic screens in yeast. J Biol Chem 278(52):52773-52782 (Pubitemid 38035875)
19. Howitz KT et al (2003) Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 425(6954):191-196 (Pubitemid 37150899)
20. Hubbert C et al (2002) HDAC6 is a microtubule-associated deacetylase. Nature 417(6887): 455-458 (Pubitemid 34563539)
21. Huber K et al (2010) Novel 3-arylideneindolin-2-ones as inhibitors of NAD+ -dependent histone deacetylases (sirtuins). J Med Chem 53(3):1383-1386
22. Imai S, Guarente L (2010) Ten years of NAD-dependent SIR2 family deacetylases: implications for metabolic diseases. Trends Pharmacol Sci 31(5):212-220
23. Kaeberlein M et al (2004) Sir2-independent life span extension by calorie restriction in yeast. PLoS Biol 2(9):E296
24. Kaeberlein M et al (2005) Substrate-specific activation of sirtuins by resveratrol. J Biol Chem 280(17): 17038-17045 (Pubitemid 41389166)
25. Kahyo T et al (2008) A novel chalcone polyphenol inhibits the deacetylase activity of SIRT1 and cell growth in HEK293T cells. J Pharmacol Sci 108(3):364-371
26. Kim EJ et al (2007) Active regulator of SIRT1 cooperates with SIRT1 and facilitates suppression of p53 activity. Mol Cell 28(2):277-290
27. Lagouge M et al (2006) Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha. Cell 127(6):1109-1122 (Pubitemid 44894520)
28. Lain S et al (2008) Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activator. Cancer Cell 13(5):454-463 (Pubitemid 351609441)
29. Lara E et al (2009) Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect. Oncogene 28(6):781-791
30. Lin SJ et al (2004) Calorie restriction extends yeast life span by lowering the level of NADH. Genes Dev 18(1):12-16
31. Mai A et al (2009) Study of 1,4-dihydropyridine structural scaffold: discovery of novel sirtuin activators and inhibitors. J Med Chem 52(17):5496-5504
32. Medda F et al (2009) Novel cambinol analogs as sirtuin inhibitors: synthesis, biological evaluation, and rationalization of activity. J Med Chem 52(9):2673-2682
33. Milne JC et al (2007) Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 450(7170):712-716 (Pubitemid 350207685)
34. Mortimer RK, Johnston JR (1959) Life span of individual yeast cells. Nature 183(4677): 1751-1752
35. Nakahata Y et al (2009) Circadian control of the NAD+ salvage pathway by CLOCK-SIRT1. Science 324(5927):654-657
36. Napper AD et al (2005) Discovery of indoles as potent and selective inhibitors of the deacetylase SIRT1. J Med Chem 48(25):8045-8054 (Pubitemid 41798434)
37. Neugebauer RC et al (2008) Structure-activity studies on splitomicin derivatives as sirtuin inhibitors and computational prediction of binding mode. J Med Chem 51(5):1203-1213 (Pubitemid 351480382)
38. North BJ et al (2003) The human Sir2 ortholog, SIRT2, is an NAD dependnet tubulin deacetylase. Mol Cell 11(2):437-444 (Pubitemid 36293837)
39. Pacholec M et al (2010) SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1. J Biol Chem 285(11):8340-8351
40. Posakony J et al (2004) Inhibitors of Sir2: evaluation of splitomicin analogues. J Med Chem 47(10):2635-2644 (Pubitemid 38580099)
41. Prozorovski T et al (2008) Sirt1 contributes critically to the redox-dependent fate of neural progenitors. Nat Cell Biol 10(4):385-394
42. Ramsey KM et al (2009) Circadian clock feedback cycle through NAMPT-mediated NAD+ biosynthesis. Science 324(5927):651-654
43. Revollo JR, Grimm AA, Imai S (2004) The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells. J Biol Chem 279(49): 50754-50763 (Pubitemid 40017813)
44. Rodgers JT et al (2005) Nutrient control of glucose homeostasis through a complex of PGC-1alpha and SIRT1. Nature 434(7029):113-118 (Pubitemid 40349395)
45. Rogina B, Helfand SL (2004) Sir2 mediates longevity in the fly through a pathway related to calorie restriction. Proc Natl Acad Sci USA 101(45):15998-16003 (Pubitemid 39507916)
46. Sauve AA et al (2005) Chemical activation of Sir2-dependent silencing by relief of nicotinamide inhibition. Mol Cell 17(4):595-601 (Pubitemid 40269123)
47. Schmidt MT et al (2004) Coenzyme specificity of Sir2 protein deacetylases: implications for physiological regulation. J Biol Chem 279(38):40122-40129 (Pubitemid 39258287)
48. Schuetz A et al (2007) Structural basis of inhibition of the human NAD+-dependent deacetylase SIRT5 by suramin. Structure 15(3):377-389 (Pubitemid 46366726)
49. Sinclair DA, Guarente L (1997) Extrachromosomal rDNA circles - a cause of aging in yeast. Cell 91(7):1033-1042 (Pubitemid 28027835)
50. Tanner KG et al (2000) Silent information regulator 2 family of NAD- dependent histone/protein deacetylases generates a unique product, 1-O-acetyl-ADP-ribose. Proc Natl Acad Sci USA 97 (26):14178-14182 (Pubitemid 32016550)
51. Tissenbaum HA, Guarente L (2001) Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans. Nature 410(6825):227-230 (Pubitemid 32216597)
52. Trapp J et al (2006) Adenosine mimetics as inhibitors of NAD+-dependent histone deacetylases, from kinase to sirtuin inhibition. J Med Chem 49(25):7307-7316 (Pubitemid 44913391)
53. Trapp J et al (2007) Structure-activity studies on suramin analogues as inhibitors of NAD+ dependent histone deacetylases (sirtuins). ChemMedChem 2(10):1419-1431
54. Vaquero A et al (2004) Human SirT1 interacts with histone H1 and promotes formation of facultative heterochromatin. Mol Cell 16(1):93-105 (Pubitemid 39330155)
55. Vaquero A et al (2006) SirT2 is a histone deacetylase with preference for histone H4 Lys 16 during mitosis. Genes Dev 20(10):1256-1261 (Pubitemid 43727586)
56. Voogd TE et al (1993) Recent research on the biological activity of suramin. Pharmacol Rev 45(2): 177-203 (Pubitemid 23191414)
57. Wood JG et al (2004) Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 430(7000):686-689 (Pubitemid 39061685)
58. Zhang Q et al (2007) Metabolic regulation of SIRT1 transcription via a HIC1:CtBP corepressor complex. Proc Natl Acad Sci USA 104(3):829-833 (Pubitemid 46154696)
59. Zhang Y et al (2009) Identification of a small molecule SIRT2 inhibitor with selective tumor cytotoxicity. Biochem Biophys Res Commun 386(4):729-733
60. Zhao W et al (2008) Negative regulation of the deacetylase SIRT1 by DBC1. Nature 451(7178): 587-590 (Pubitemid 351186268)